NFT
ABEO icon

Nan Fung Trinity’s Abeona Therapeutics ABEO Stock Holding History

Nan Fung Trinity’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91M Hold
956,770
– – 0.58% 46
2026
Q1 		$4.29M Hold
956,770
– – 0.47% 48
2025
Q4 		$5.04M Buy
956,770
+396,000
+71% +$1.99M 0.4% 64
2025
Q3 		$2.96M Hold
560,770
– – 0.3% 58
2025
Q2 		$3.19M Buy
+560,770
New +$3.19M 0.38% 52

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nan Fung Trinity's ABEO Position: Q2 2026 in Review

Nan Fung Trinity held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 956,770 shares worth $5.91M. The position accounts for 0.58% of the portfolio, ranked #46.

Nan Fung Trinity first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Nan Fung Trinity held 956,770 shares of Abeona Therapeutics worth $5.91M as of Q2 2026.
  • Nan Fung Trinity left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up 0.58% of Nan Fung Trinity's portfolio in Q2 2026, its #46 holding.
  • Nan Fung Trinity first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.